Apogee Therapeutics, Inc. APGE Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Apogee Therapeutics, Inc. (APGE) reported deferred tax assets and other non-current assets of $8.52M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Apogee Therapeutics, Inc.'s deferred tax assets and other non-current assets increased by 16.0% year-over-year, from $7.34M to $8.52M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a 365.0% compound annual growth rate (CAGR), from $401K to $8.67M.